Skip to Main Content

Paper Details

Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study.
Lancet HIV
14
2023
AIDS, Allergy, Cabotegravir, HIV, cabotegravir, dolutegravir, integrase, people
Author NameAffiliation
Daniel R KuritzkesBrigham and Women's Hospital, Harvard Medical School
Daniel R KuritzkesBrigham and Women's Hospital, Harvard Medical School
Raphael J LandovitzDavid Geffen School of Medicine, University of California, USA Center for Clinical AIDS Research and Education los angeles
Raphael J LandovitzDavid Geffen School of Medicine, University of California, USA Center for Clinical AIDS Research and Education los angeles
Robert W ShaferStanford University
Roger ParedesIrsi Caixa Institut de Recerca de la SIDA
  • 1 - 6

Datasets

Release 1.2